Literature DB >> 3987346

Intraocular penetration of systemically administered antifungal agents.

D M O'Day, W S Head, R D Robinson, W H Stern, J M Freeman.   

Abstract

Amphotericin B, 5-flucytosine (5-FC), and ketoconazole levels were estimated in vitreous and aqueous samples taken from four patients undergoing therapeutic vitrectomy for fungal endophthalmitis. The levels of amphotericin B in the vitreous of three patients were low (.04 - .17 microgram/ml). However, 5-FC was present in a concentration of 22.2 micrograms/ml in one patient. In another case the aqueous level of ketoconazole was 0.35 microgram/ml. The vitreous in the same patient contained 0.71 microgram/ml of the drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987346     DOI: 10.3109/02713688508999978

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  18 in total

1.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

2.  Ocular toxicity of experimental intravitreal itraconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

3.  Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.

Authors:  D V Savani; J R Perfect; L M Cobo; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.

Authors:  David Goldblum; Kaspar Rohrer; Beatrice E Frueh; Regula Theurillat; Wolfgang Thormann; Stefan Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis.

Authors:  Jeong Hun Bae; Sung Chul Lee
Journal:  Jpn J Ophthalmol       Date:  2015-07-28       Impact factor: 2.447

Review 6.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

7.  An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.

Authors:  D M O'Day; W S Head; R D Robinson
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

8.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

9.  Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole.

Authors:  S S Park; D J D'Amico; B Paton; A S Baker
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

10.  Toxicity of intravitreal oxiconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella
Journal:  Int Ophthalmol       Date:  1989-05       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.